Supreme Court Restores Mifepristone Mail Access

Justice Samuel Alito of the United States — Supreme Court of the United States temporarily halted an appellate court order that blocked a United States — Food and Drug Administration rule allowing the abortion pill Mifepristone to be prescribed online and dispensed through the mail. This action provided temporary relief to Abbott Laboratories and GenBioPro, the manufacturers of Mifepristone and its generic version, respectively. The United States — Supreme Court of the United States later paused the U.S. Court of Appeals for the 5th Circuit's decision, allowing patients to continue accessing Mifepristone by mail while litigation proceeds. This legal battle stems from a lawsuit filed by United States — Louisiana challenging the United States — Food and Drug Administration's rule, arguing it undermines the state's abortion ban. The U.S. Court of Appeals for the 5th Circuit had temporarily reinstated an in-person pickup requirement for Mifepristone, which Abbott Laboratories and GenBioPro appealed to the United States — Supreme Court of the United States. Justices Clarence Thomas and Samuel Alito dissented from the Supreme Court's decision to pause the appellate court's ruling. The United States — Food and Drug Administration is currently conducting a safety review of Mifepristone.